272 related articles for article (PubMed ID: 26597313)
1. Platelet-derived microparticles trigger THP-1 monocytic cell aggregation and release of pro-coagulant tissue factor-expressing microparticles in vitro.
Lin HC; Chang HW; Hsiao SH; Chou ML; Seghatchian J; Burnouf T
Transfus Apher Sci; 2015 Oct; 53(2):246-52. PubMed ID: 26597313
[TBL] [Abstract][Full Text] [Related]
2. Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability.
Aleman MM; Gardiner C; Harrison P; Wolberg AS
J Thromb Haemost; 2011 Nov; 9(11):2251-61. PubMed ID: 21883880
[TBL] [Abstract][Full Text] [Related]
3. Activity of Tissue Factor in Microparticles Produced in vitro by Endothelial Cells, Monocytes, Granulocytes, and Platelets.
Khaspekova SG; Antonova OA; Shustova ON; Yakushkin VV; Golubeva NV; Titaeva EV; Dobrovolsky AB; Mazurov AV
Biochemistry (Mosc); 2016 Feb; 81(2):114-21. PubMed ID: 27260391
[TBL] [Abstract][Full Text] [Related]
4. Differential procoagulant activity of microparticles derived from monocytes, granulocytes, platelets and endothelial cells: impact of active tissue factor.
Shustova ON; Antonova OA; Golubeva NV; Khaspekova SG; Yakushkin VV; Aksuk SA; Alchinova IB; Karganov MY; Mazurov AV
Blood Coagul Fibrinolysis; 2017 Jul; 28(5):373-382. PubMed ID: 27926582
[TBL] [Abstract][Full Text] [Related]
5. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine.
Burnouf T; Goubran HA; Chou ML; Devos D; Radosevic M
Blood Rev; 2014 Jul; 28(4):155-66. PubMed ID: 24826991
[TBL] [Abstract][Full Text] [Related]
6. Platelet microparticles and cancer: An intimate cross-talk.
Goubran H; Sabry W; Kotb R; Seghatchian J; Burnouf T
Transfus Apher Sci; 2015 Oct; 53(2):168-72. PubMed ID: 26542350
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.
Mobarrez F; He S; Bröijersen A; Wiklund B; Antovic A; Antovic J; Egberg N; Jörneskog G; Wallén H
Thromb Haemost; 2011 Aug; 106(2):344-52. PubMed ID: 21614411
[TBL] [Abstract][Full Text] [Related]
8. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
Christersson C; Thulin Å; Siegbahn A
Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the size of membrane microparticles of different cellular origin by dynamic light scattering.
Alchinova IB; Khaspekova SG; Golubeva NV; Shustova ON; Antonova OA; Karganov MY; Mazurov AV
Dokl Biochem Biophys; 2016 Sep; 470(1):322-325. PubMed ID: 27817018
[TBL] [Abstract][Full Text] [Related]
10. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa.
Van Der Meijden PE; Van Schilfgaarde M; Van Oerle R; Renné T; ten Cate H; Spronk HM
J Thromb Haemost; 2012 Jul; 10(7):1355-62. PubMed ID: 22537188
[TBL] [Abstract][Full Text] [Related]
11. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
12. [Coagulation properties of erythrocyte derived membrane microparticles].
Antonova OA; Shustova ON; Golubeva NV; Yakushkin VV; Alchinova IB; Karganov MY; Mazurov AV
Biomed Khim; 2019 Apr; 65(3):214-221. PubMed ID: 31258144
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Plasma Platelet Microparticles in Thrombotic Thrombocytopenic Purpura.
Tahmasbi L; Karimi M; Kafiabadi SA; Nikougoftar M; Haghpanah S; Ranjbaran R; Moghadam M
Ann Clin Lab Sci; 2017 Jan; 47(1):62-67. PubMed ID: 28249919
[TBL] [Abstract][Full Text] [Related]
14. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
[TBL] [Abstract][Full Text] [Related]
15. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived microparticles during and after acute coronary syndrome.
Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
[TBL] [Abstract][Full Text] [Related]
17. Impact of Early Microparticle Release during Isolated Severe Traumatic Brain Injury: Correlation with Coagulopathy and Mortality.
Albert V; Subramanian A; Pati HP
Neurol India; 2024 Mar; 72(2):285-291. PubMed ID: 38691471
[TBL] [Abstract][Full Text] [Related]
18. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
Morel O; Morel N; Freyssinet JM; Toti F
Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
[TBL] [Abstract][Full Text] [Related]
19. Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity.
Boles JC; Williams JC; Hollingsworth RM; Wang JG; Glover SL; Owens AP; Barcel DA; Kasthuri RS; Key NS; Mackman N
Thromb Res; 2012 Feb; 129(2):197-203. PubMed ID: 21762960
[TBL] [Abstract][Full Text] [Related]
20. Formation of microparticles in the injured brain of patients with severe isolated traumatic brain injury.
Nekludov M; Mobarrez F; Gryth D; Bellander BM; Wallen H
J Neurotrauma; 2014 Dec; 31(23):1927-33. PubMed ID: 24956150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
